Viewing StudyNCT00258297



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258297
Status: TERMINATED
Last Update Posted: 2013-10-16
First Post: 2005-11-22

Brief Title: Gefitinib in Treating Patients With Stage I Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery
Sponsor: University of Rochester
Organization: University of Rochester

Conditions & Keywords Data

Conditions:
Name
Esophageal Cancer
Keywords:
Name View
squamous cell carcinoma of the esophagus View
stage I esophageal cancer View
stage II esophageal cancer View
stage III esophageal cancer View
adenocarcinoma of the esophagus View